Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06219889 · ClinicalTrials.gov registry record · NA
Short-term And Longer-term Cognitive Impact Of Neurochecks
A NA study of Intracerebral Hemorrhage, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06219889: Recruiting NA study of Intracerebral Hemorrhage, sponsored by University of California, San Diego.
NCT06219889 is a NA study of Intracerebral Hemorrhage that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 120 participants, below the 1,102-participant average among 31 other Intracerebral Hemorrhage trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06219889, a NA study of Intracerebral Hemorrhage, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed research plan seeks to understand the impact of sleep disruption in the Neurological Intensive Care Unit (ICU) on older patients with acute brain injury (ABI). In current practice, the neurocritical care community performs frequent serial neurological examinations ("neurochecks") in an effort to monitor patients for neurological deterioration following brain injury. Many neurocritical patients are older and/or cognitively fragile, and delirium is common. Although ICU delirium is multifaceted, frequent neurochecks may represent a modifiable risk factor if the investigators can better understand the risks and benefits of various neurocheck frequencies. This project will randomize patients with acute spontaneous intracerebral hemorrhage (ICH) to either hourly (Q1) or every-other-hour (Q2) neurochecks and evaluate the impact of neurocheck frequency on delirium. Second, longer-term cognitive outcomes will be investigated in patients with ICH randomized to Q1 versus Q2 neurochecks with the goal of identifying whether hourly neurochecks increase the risk for dementia.
Primary Outcome
Cumulative duration (in multiple of 0.5 days) of incident delirium
Conditions Studied
Interventions
- BEHAVIORAL Frequency of neurochecks
Study Locations (1)
California
- UC San Diego Health - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-07-08 |
| Est. Completion | 2029-10-31 |
| Phase | NA |
What NCT06219889 shows while recruiting
NCT06219889 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,102-participant average among 31 other Intracerebral Hemorrhage trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Intracerebral Hemorrhage appearing as the primary indexed condition, and to 1 intervention - of which Frequency of neurochecks is the first listed.
NCT06219889 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06219889 about?
NCT06219889 is a clinical study titled "Short-term And Longer-term Cognitive Impact Of Neurochecks". The proposed research plan seeks to understand the impact of sleep disruption in the Neurological Intensive Care Unit (ICU) on older patients with acute brain injury (ABI). In current practice, the neurocritical care community performs frequent serial neurological examinations ("neurochecks") in an ...
What is the current status of trial NCT06219889?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2024-07-08. Estimated completion is 2029-10-31.
What conditions does trial NCT06219889 study?
This clinical trial studies the following conditions: Intracerebral Hemorrhage.
What interventions are being tested in trial NCT06219889?
The interventions under investigation include: Frequency of neurochecks (BEHAVIORAL).
Who is sponsoring clinical trial NCT06219889?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06219889 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intracerebral Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06219889's enrollment target sits among peer trials
120 20th of 31 higher than 11 of 31 other Intracerebral Hemorrhage trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Intracerebral Hemorrhage trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Auricular VNS Following Intracerebral Hemorrhage
RECRUITING · NA
-
Evaluating a Prototype CT Scan for ICH Evacuation
RECRUITING · NA
-
Implementation of Neuro Lung Protective Ventilation
ACTIVE NOT RECRUITING · NA
-
Stroke and CPAP Outcome Study 3
COMPLETED · NA
-
Hemodynamic ABI Monitor
RECRUITING
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI